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N euroendocrine tumors are a rare type of neoplasms that comprise only 0.5% of all malignancies. 1 Tey usually arise from the gastrointestinal tract and the lung. 1, 2 Neuroendocrine carcinoma of the head and neck is a relatively rare malignancy described in the literature. Te larynx is the most commonly afected region of the head and neck. 3, 4 Nevertheless, smallcell carcinoma comprises only 0.5% of all laryngeal cancers. 5 Neuroendocrine carcinoma of the larynx carries variable prognosis depending on the histological subtype. 6 Typical carcinoid rarely metastasizes, but atypical carcinoid and small-cell carcinoma have high rates of metastasis, usually in the lung and liver. 2 Cutaneous metastasis from neuroendocrine carcinoma is an extremely rare entity, with only few cases reported in the English literature. 7, 8 We report the case of an elderly man with recurrent laryngeal neuroendocrine carcinoma with metastasis to the eyelid.
Case presentation and summary
An 85-year-old man initially presented to the ear, nose, and throat clinic in September 2007 with a few months' history of hoarseness and foreign body sensation in the throat. He had an 80 pack-year smoking history, and he had quit 30 years prior to presentation. Flexible fber-optic laryngoscopy revealed an erythematous polyp of 2-3 mm in the right posterior aspect of the supraglottic area. Te results of a computerized-tomography (CT) scan of the neck showed a mucosal irregularity of less than 1 cm in the inferior posterior right false cord level near the arytenoid, with no evidence of adenopathy ( Figure  1) . A CT scan of the chest and abdomen did not show evidence of metastasis. Excisional biopsy of the polypoid lesion was performed, and histopathological examination of the specimen revealed moderately diferentiated neuroendocrine carcinoma (Figure 2A) . A wider excision of 1 cm was made, but there was no malignant tissue. Based on those results, the tumor was put at stage I (T1N0M0). Te patient did not receive adjuvant therapy. He was followed up with regular CT scans, which revealed stable examination.
Tree and a half years later, in March 2011, the patient developed a skin lesion over his posterior scalp. Biopsy showed linear groups and nests of mitotically active atypical cells invading the dermis. Te cells had fne chromatin and were positive for chromogranin and synaptophysin stains, confrming their neuroendocrine diferentiation. S100 stain was negative, ruling out paraganglioma. Te tumor cells were histologically similar to those seen in the patient's previous biopsy. Further evaluation for local recurrence of disease and distant metastasis was pursued. A CT scan of the chest and abdomen and magnetic-resonance imaging of the brain were negative. However, laryngoscopy showed biopsyproven local recurrence in the right supraglottis. Te patient underwent surgical resection of recurrent supraglottic tumor as well as the solitary skin metastasis. He underwent radiation therapy to the skin lesion, but declined radiation therapy to his larynx. He received systemic chemotherapy with carboplatin and etoposide; however, he completed only 3 cycles owing to persistent thrombocytopenia. In 2012, he had recurrence of symptoms including hoarseness. Flexible fber-optic laryngoscopy was performed and showed disease progression in the supraglottic area. He received palliative radiation to the larynx. During the next 2 years, the patient had more than 5 solitary skin biopsy-proven skin metastases, including the left upper eyelid (Figure 2B ), all of which been managed by local excision.
Discussion
Neuroendocrine carcinoma is a pluriform group of rare tumors with increasing incidence over the past decade. 1 Although it is most common in the lung and gastrointestinal tract, it has been described in almost every organ system, including the head and neck. 9 According to a retrospective analysis of 1,618 cases of extrapulmonary small cell cancer, 11% arose from the head and neck region. 10 Te larynx seems to be the most common region of the head and neck in which neuroendocrine carcinoma arises from, 3, 11 although the latter makes up less than 1% of all laryngeal cancers. 3 More than 500 cases of primary laryngeal neuroendocrine tumors have been described in the literature. 12 Neuroendocrine carcinoma of the larynx was frst reported in 1969 by Goldman and colleagues, who described a welldiferentiated carcinoid tumor. 13 In 1983, Duvall and colleagues 14 were the frst to report an atypical carcinoid tumor in the larynx. It wasn't until 1991 that a formal classifcation of the diferent histological subtypes was formalized by the World Health Organiztion. 15 Neuroendocrine carcinoma of the larynx is categorized into 2 main groups: tumors of epithelial origin and tumors of neural origin (paragangliomas). Te epithelial group is further subdivided into 3 subgroups according to grade of diferentiation: typical carcinoid (well-diferentiated tumors), atypical carcinoid (moderately diferentiated tumors), and small-cell carcinoma (poorly diferentiated tumors). Tese diferent biological behaviors ultimately translate clinically into varying response to treatment and diferent prognoses between the subtypes. 12 Terefore, diagnostic accuracy is very important in guiding therapy as well as predicting clinical outcome.
In our case report, the patient had early stage, moderately diferentiated neuroendocrine carcinoma, that is, atypical carcinoid tumor. Atypical carcinoid tumor is the most common sybtype. 16 It carries a better prognosis compared with small-cell carcinoma, but a worse prognosis than typical carcinoid. 6 Te literature on neuroendocrine carcinoma is derived mainly from case reports and case series, so there is little data on long-term survival and treatment strategies for the various histological subtypes. A meta-analysis of 436 reported cases of neuroendocrine carcinoma of the larynx was published in 2014, 6 with the aim of providing clinicians with more insight into the clinical and treatment outcome of afected patients. According the analysis, 30% of patients with atypical carcinoid tumor have distant metastasis at presentation. Te recurrence rate was at 62.5%, with a 5-year disease-free survival and overall survival of 52.8% and 46%, respectively. In regard to the treatment modality, the study seems to emphasize the importance of radical surgical resection in improving disease-free survival, while showing no role for postoperative radiation therapy. Tis is in contrast to an editorial written by members of the International Head and Neck Scientifc Group and published in 2011, 17 which ofers local resection with or without neck dissection as reasonable options, in addition to postoperative radiotherapy in node-positive patients. Tis highlights the need for large multicenter retrospective studies to address these discrepancies.
In our patient, the early stage tumor was initially managed with local resection, yielding a disease-free survival of 3.5 years. Te patient had both local recurrences, treated with further resection, chemotherapy and radiation ther-apy, and recurrent distant metastases, all of which were solitary skin metastases. Te usual sites of metastasis originating from neuroendocrine carcinoma include the lung and liver, 2 with cutaneous metastasis being very uncommon. As far as we know, we report the frst case of a recurrent neuroendocrine carcinoma of the larynx with metastasis to the eyelid. Laryngeal neuroendocrine malignancy is a rare entity, and subsequent cutaneous metastasis is even more unusual. Histopathological examination of the specimen is of paramount importance to distinguish between diferent subtypes. Tis, in return, has a signifcant impact on the patient's treatment modalities and prognosis.
